McDermott Advises Cilcare on a EUR40 Million Series A Financing Round
December 14, 2024
December 14, 2024
CHICAGO, Illinois, Dec. 14 -- McDermott Will and Emery, a law firm, issued the following news release:
McDermott Will & Emery has advised Cilcare, a biotech company specializing in hearing sciences, on the completion of a EUR 40 million Series A round to accelerate the development of innovative treatments for early hearing loss.
The round brought together new investors SHIONOGI & CO LTD, Sprim Global Investments Pte. Ltd, as well as long-standing investors Sofil . . .
McDermott Will & Emery has advised Cilcare, a biotech company specializing in hearing sciences, on the completion of a EUR 40 million Series A round to accelerate the development of innovative treatments for early hearing loss.
The round brought together new investors SHIONOGI & CO LTD, Sprim Global Investments Pte. Ltd, as well as long-standing investors Sofil . . .